Pollogen’s technologies are a global industry standard and we proud to be representing them in Colombia. We can now offer our clinics superior medical devices that deliver significant aesthetic results, an opportunity to build long term success.
(PRWEB) July 18, 2013
Pollogen Ltd., a global leader in the development of medical devices for the aesthetics market, announced that it has entered into an exclusive partnership with Tecnolaser in Bogota, Colombia. Tecnolaser, will be responsible for integrating Maximus Platform by Pollogen into aesthetic clinics and medi-spas as well as providing all clinical and technical support.
The Maximus platform, is a unique aesthetic medical device housing 3 technologies that allows practitioners to treat all four layers of the skin simultaneously and significantly improve most facial and body areas.
Facial results include both anti-aging and skin texture correction–with many successful cases of wrinkle reduction, lax skin tightening, and skin rejuvenation. Dramatic body results include localized fat reduction, cellulite treatment, stretch marks improvement and a decrease in circumference.
The Maximus platform includes renowned TriFractional– an advanced fractional RF resurfacing technology. TriFractional is ideal both for anti-aging and skin texture improvement. TriFractional successfully treats wrinkles, facial acne scars, stretch marks, body scars and a wide range of other skin imperfections. Procedures require minimal downtime.
The safety and effectiveness of the Maximus was recently validated in a peer reviewed article published in The Journal of Cosmetics, Dermatological Sciences and Applications.
During the clinical study, 20 women aged 35 - 65 received 8 weekly facial treatments. Results demonstrated significant wrinkle reduction, improvement in skin tonus and dramatic facial skin lift effect.
Ms. Alicia Rojas Sales Manager at Tecnolaser: "Pollogen’s technologies are a global industry standard and we proud to be representing them in Colombia. With Pollogen’s solution we can offer our clinics superior medical devices that deliver significant aesthetic results, an opportunity to build long term success and boost revenue."
Pollogen ‘s CEO Mr. Amichai Bar-Nir:
"We look forward to working with Tecnolaser and are sure that their expertise and knowledge of the Colombian market are a good fit for us. We are confident that the Maximus will be quickly adopted by the medical aesthetic community and become a go-to reference aesthetic solution in Colombia just like in the rest of Latin America. Pollogen realizes that delivering exceptional-quality solutions and results are critical to running a successful aesthetic practice. Pollogen stands behinds its partners and is dedicated to providing high patient satisfaction and a genuine business profitability opportunity."
We believe in constantly challenging ourselves to create the most advanced, effective medical aesthetic technologies and solutions. We believe in thinking differently.
In everything we do, we take a customer-centric approach by making our products user-friendly, safe and convenient. At Pollogen there is no such word as “done”; we continually perfect our solutions to provide treatments that are pleasant and effective. We believe in finding ways to develop technologies that work with the body’s natural mechanisms so beautiful results are generated from within.
Pollogen is the developer and manufacturer of five revolutionary technologies under the industry premier brand names OxyGeneo™, Hybrid Energy™, TriPollar®, TriLipo® and TriFractional™. We offer a full line of clinically-proven, safe and effective, non-invasive anti-aging facial and body contouring treatment platforms for a wide range of aesthetic applications. Pollogen provides solutions for professionals in over 60 countries, addressing the specific needs and dynamic changes unique to the ever-evolving aesthetic industry.